Page results
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
UCLH has achieved excellent results in the 2024 National Adult Inpatient Survey, with patients rating their overall care 8.4 out of 10. This gives UCLH the second highest score of London’s acute teaching hospitals.
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
We’re proud that UCLH is ranked number one of all acute teaching trusts in new national league tables published today.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
File results
-
FOI/2022/0705 - Head/ neck and urothelial cancer treatment
-
FOI/2022/0707 - Current endoscopy maintenance supplier and the contract expiry date
-
FOI/2022/0709 - Non-detained mental heath patients
-
FOI/2022/0712 - Holmium Laser Enucleation of the Prostate (HoLEP) as a surgical intervention
-
FOI/2022/0713 - Ambulance deaths
-
FOI/2022/0714 - Number of births/ number of attendances of antenatal classes
-
FOI/2022/0716 - Trust structure/ organisation charts
-
FOI/2022/0717 - Digital Healthcare organisation chart
-
FOI/2022/0718 - Clinical service incidents caused by estates and infrastructure in 2021/22
-
FOI/2022/0722 - Procedures for patients on lateral flow tests and wearing masks in hospital